TABLE 4 from The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC
Year: 2023
Type: other
Abstract: Worst treatment-related toxicity logistic regression model of KRAS and cetuximab interaction
Authors: Joanne B. Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein, Joe Y. Chang, Bo Lu, Adam P. Dicker, Jeffrey A. Bogart, Yolanda I. Garces, Samir Narayan, Clifford G. Robinson, Vivek S. Kavadi, Joel S. Greenberger, Christopher D. Koprowski, James Welsh, Elizabeth M. Gore, Robert M. MacRae, Rebecca Paulus, Jeffrey D. Bradley
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4387528342